Shoulder Innovations (NYSE:SI) Major Shareholder Healthcare Holding B.V. Gilde Sells 681 Shares

Key Points

• Major shareholder Healthcare Holding B.V. Gilde sold 681 Shoulder Innovations shares at an average price of $22.62, reducing its stake by 0.03% while retaining approximately 2.19 million shares worth $49.5 million. The sale followed several other disposals in recent weeks.
• Shoulder Innovations shares rose 0.8% to $22.24, with the stock trading well above its 200-day moving average. However, the company reported a quarterly loss of $0.49 per share, missing analyst expectations, on revenue of $17.18 million.
• Analyst sentiment remains positive, with six Buy ratings, one Hold and one Sell; the consensus rating is Moderate Buy and the average price target is $23.50, while recent targets range as high as $28.

Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) major shareholder Healthcare Holding B.V. Gilde sold 681 shares of the company's stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $22.62, for a total value of $15,404.22. Following the sale, the insider directly owned 2,187,110 shares in the company, valued at approximately $49,472,428.20. This represents a 0.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.61, for a total transaction of $463,866.76.
• On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total value of $88,140.00.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.64, for a total transaction of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total transaction of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total value of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total value of $659,803.20.

Shoulder Innovations Stock Up 0.8%

SI stock traded up $0.18 during mid-day trading on Monday, hitting $22.24. The stock had a trading volume of 75,051 shares, compared to its average volume of 128,345. Shoulder Innovations, Inc. has a 1-year low of $10.92 and a 1-year high of $24.59. The company has a fifty day moving average of $21.03 and a 200 day moving average of $16.60. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $463.02 million and a price-to-earnings ratio of -11.58.

Shoulder Innovations (NYSE:SI - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.46) by ($0.03). Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%.The business had revenue of $17.18 million for the quarter. On average, equities analysts expect that Shoulder Innovations, Inc. will post -1.9 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on SI. Weiss Ratings upgraded shares of Shoulder Innovations from a "sell (d-)" rating to a "sell (d)" rating in a research note on Monday, August 3rd. Piper Sandler restated an "overweight" rating and set a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a research report on Friday, August 7th. BTIG Research lifted their price objective on Shoulder Innovations from $24.00 to $26.00 and gave the company a "buy" rating in a research report on Friday, August 7th. Finally, UBS Group boosted their price objective on Shoulder Innovations from $27.00 to $28.00 and gave the stock a "buy" rating in a research note on Monday, August 10th. Six research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $23.50.

Institutional Trading of Shoulder Innovations

Hedge funds have recently modified their holdings of the stock. Compass Financial Management LLC acquired a new stake in shares of Shoulder Innovations during the second quarter valued at about $30,000. Wells Fargo & Company MN boosted its position in Shoulder Innovations by 66.3% during the 4th quarter. Wells Fargo & Company MN now owns 5,250 shares of the company's stock worth $75,000 after buying an additional 2,094 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Shoulder Innovations during the 3rd quarter worth approximately $28,000. California State Teachers Retirement System increased its position in Shoulder Innovations by 412.4% in the 2nd quarter. California State Teachers Retirement System now owns 2,941 shares of the company's stock valued at $60,000 after acquiring an additional 2,367 shares during the period. Finally, Rhumbline Advisers bought a new position in shares of Shoulder Innovations during the third quarter valued at $54,000.

Shoulder Innovations Company Profile

Shoulder Innovations NYSE: SI is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source